Michael A. DesJardin, EVP, Technical Operations at Horizon Therapeutics Public Ltd Co (HZNP), sold 23,300 shares at $87.20 ($2.1M) on 2021-02-24, disclosed to the SEC on 2021-02-26.
Seasonal sale ($2.1M) by EVP, Technical Operations — this insider has traded HZNP in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.20 | 5,158 | $450K | 21.2% |
| 2 | $87.20 | 5,158 | $450K | 21.2% |
| 3 | $95.00 | 10,786 | $1.0M | 48.2% |
| 4 | $91.83 | 1,099 | $101K | 4.7% |
| 5 | $91.83 | 1,099 | $101K | 4.7% |
| Total | $91.25 avg | 23,300 |
| $2.1M |
| 100% |
| Filing → |
| HZNP | SELL | 2021-02-12 | $971K | — | Filing → |
| HZNP | SELL | 2021-02-04 | $385K | — | Filing → |
| HZNP | SELL | 2021-01-08 | $2.0M | — | Filing → |